Endovia Health Sciences earnings were -$18.5M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest EDVA earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$2.1M, down 18.2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, EDVA reported annual earnings of -$26.1M, with 9.7% growth.
Endovia Health Sciences Earnings Reports & History FAQ
What were Endovia Health Sciences's earnings last quarter?
On EDVA's earnings call on Aug 20, 2026, Endovia Health Sciences (NYSEMKT: EDVA) reported Q2 2026 earnings per share (EPS) of -$0.79, up 95.68% year over year. Total EDVA earnings for the quarter were -$2.05 million. In the same quarter last year, Endovia Health Sciences's earnings per share (EPS) was -$18.29.
Is Endovia Health Sciences profitable or losing money?
As of the last Endovia Health Sciences earnings report, Endovia Health Sciences is currently losing money. Endovia Health Sciences's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$17.28 million, a 33.28% decrease year over year.
What was EDVA's earnings growth in the past year?
As of Endovia Health Sciences's earnings date in Aug 20, 2026, Endovia Health Sciences's earnings has grown year over year. EDVA earnings in the past year totalled -$18.49 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.